• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. ENDOBON® XENOGRAFT GRANULES 0.5ML; BONE GRAFTING MATERIAL, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. ENDOBON® XENOGRAFT GRANULES 0.5ML; BONE GRAFTING MATERIAL, SYNTHETIC Back to Search Results
Model Number N/A
Device Problem Failure to Osseointegrate (1863)
Patient Problem Inadequate Osseointegration (2646)
Event Date 07/01/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).(b)(6).The device was not returned to the manufacturer.Therefore it could not be analyzed the device manufacturing quality record indicates that the released product met all requirements to perform as intended.According to the available data, the exact root cause cannot be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that following non integration of the biomaterial, the bone material was not compacted causing an implant failure.The biomaterial was placed on (b)(6) 2017, the implant was placed on (b)(6) 2017 and non integration appeared on (b)(6) 2018.
 
Event Description
It has been reported that following non integration of the biomaterial, the bone material was not compacted causing an implant failure.The biomaterial was placed on (b)(6) 2017, the implant was placed on (b)(6) 2017 and non integration appeared on (b)(6) 2018.
 
Manufacturer Narrative
(b)(4).This follow-up report is being filled to relay additional information, which was unknown at the time of the initial medwatch.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOBON® XENOGRAFT GRANULES 0.5ML
Type of Device
BONE GRAFTING MATERIAL, SYNTHETIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key8266249
MDR Text Key133708998
Report Number3006946279-2019-00058
Device Sequence Number1
Product Code LYC
UDI-Device Identifier03599870091258
UDI-Public03599870091258
Combination Product (y/n)N
PMA/PMN Number
K110449
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 04/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/22/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberN/A
Device Catalogue NumberROX05
Device Lot NumberX0072187
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received04/01/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-